Problemi speciali
Ipopituitarismo congenito
Congenital hypopituitarism
Patrizia Matarazzo1, Marialia Repici1, Aldo Ravaglia2
1Endocrinologia Pediatrica, Ospedale Infantile Regina Margherita, Città della Salute e della Scienza, Torino
2Pediatra ASL TO 4
Settembre 2015 - pagg. 452 -457
Abstract
A lot of genes govern pituitary gland development, differentiation and function. Mutations
in those genes, as well as toxic or infective intrauterine noxae, could derange pituitary
gland development, differentiation and function. More precocious is the damage or
more extended the genetic mutation, more severe will be the anatomical defect of hypothalamo-
pituitary axis and consequently clinical and hormonal picture of congenital
hypopituitarism. Hormonal deficiencies can be present at diagnosis in more severe disease
or can develop later in life. For this reason, follow up is mandatory in children affected
by congenital hypopituitarism. Frequently, congenital hypopituitarism is associated
with some disabilities (severe obesity, neuromotor impairment, visual damage, all of
them due to midline malformations) that could worse the clinical outcome. Precocious detection
and substitutive treatment of hormonal deficiencies, multidisciplinary care, patient/
family education, especially in particular moments of life, as at the transition from
paediatric to adulthood structures, are necessary to improve quality of life in children affected
by congenital hypopituitarism.
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Bancalari RE, Gregory LC, McCabe MJ,
Dattani MT. Pituitary gland development: an
update. In: Mullis P-E (Ed). Developmental
biology of GH secretion, growth and treatment.
Endocr Dev. Basel: Karger, 2012;23:1-
15.
2. Romero CJ, Pine-Twaddel E, Radovick S.
Novel mutations associated with combined pituitary
hormone deficiency. J Mol Endocrinol
2011;46:R93-R102.
3. Takagi M, Ishii T, Inokuchi M, et al. Gradual
loss of ACTH due to a novel mutation in
LHX4: comprehensive mutation screening in
japanese patients with congenital hypopituitarism.
PLoS ONE 2012;7(9):e46008.
4. Webb EA, Dattani MT. Septo-optic dysplasia.
Eur J Hum Genet 2010;18:393-7.
5. Lifshitz F. Pediatric endocrinology, fifth Ed.
Vol. 2. Growth, adrenal, sexual, thyroid, calcium,
and fluid balance disorders (HBK), 2006.
6. Tsai SL, Laffan E, Lawrence S. A retrospective
review of pituitary MRI findings in children
on growth hormone therapy. Pediatr Radiol
2012;42:799-804.
7. Di Iorgi N, Maghnie M. Pituitary gland imaging
and outcome. Endocr Dev 2012;23:16-29.
8. Stanhope R. Transition from paediatric to
adult endocrinology: hypopituitarism. Growth
Horm IGF Res 2004;14:S85-8.
Corrispondenza: pmatarazzo@cittadellasalute.to.it
